Sector Watch: Healthcare - May 15 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $106.58 -1.10 -1.02% | XBI: $92.28 -0.55 -0.59% | Updated May 15, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| MEIP52WH MEI Pharma $126.0M |
3.40+0.87 3.8 M 19.7x |
34% | ||
| PFNX52WH Pfenex $188.7M |
8.00+1.90 1.1 M 15.4x |
31% | ||
| ONVO Organovo Holdings $192.9M |
1.74+0.19 2.7 M 2.7x |
12% | ||
| RMTI Rockwell Medical $312.7M |
6.04+0.61 511.6 K 2.7x |
11% | ||
| XENE52WH Xenon Pharmaceuticals $94.2M |
6.65+0.65 963.4 K 7.9x |
11% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| ICAD Icad $56.8M |
3.41-0.51 138.6 K 5.7x |
-13% | ||
| HSGX Histogenics $61.7M |
2.15-0.30 279.1 K 5.7x |
-12% | ||
| PTN Palatin Technologies $236.4M |
1.21-0.12 3.5 M |
-9% | ||
| VTVT VTv Therapeutics $53.2M |
1.62-0.16 610.7 K |
-9% | ||
| PBH Prestige Brand Holdings $1.8B |
34.59-3.39 1.9 M 2.0x |
-9% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Biotech Sector Volatile Ahead of Trump Announcement [prnewswire.com]Xenon Presents Positive XEN1101 TMS Pharmacodynamic Phase 1 Data at 14th Eilat Conference [globenewswire.com]
Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference [globenewswire.com]
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and [prnewswire.com]
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 [prnewswire.com]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference [globenewswire.com]
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for [prnewswire.com]
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018 [prnewswire.com]
iCAD Reports First Quarter 2018 Financial Results [globenewswire.com]
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results Nasdaq:ONVO [globenewswire.com]
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and [prnewswire.com]
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 [prnewswire.com]
Rockwell Medical Reports First Quarter 2018 Results [globenewswire.com]
Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial ? New Research Emphasizes Economic Growth [globenewswire.com]
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress [globenewswire.com]
Prestige Brands Holdings, Inc. Reports Fiscal 2018 Fourth Quarter and Full Year Results; Provides Fiscal 2019 Outlook [globenewswire.com]
Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results [globenewswire.com]
vTv Therapeutics Announces Company will Pre-specify New Subgroup with the FDA and Report Phase 3 Part B Results in June | Business Wire [businesswire.com]
MEI Pharma Reports Third Quarter Fiscal Year 2018 Results [prnewswire.com]
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: [prnewswire.com]
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts [prnewswire.com]
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update [globenewswire.com]
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA [globenewswire.com]
iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018 [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
